European Research Infrastructure on Highly Pathogenic Agents — Association internationale sans but lucratif in Ixelles
European Research Infrastructure on Highly Pathogenic Agents is a Belgian company registered with the Crossroads Bank for Enterprises (KBO/BCE) under number 0679.481.238. Incorporated as a Association internationale sans but lucratif, it is currently Active, with its registered office located in Ixelles. According to official KBO/BCE records, the company was registered on 01 August 2017. This page consolidates all publicly available information: address, directors, main economic activity, branches and tax identifiers.
Company identity
- KBO/BCE number: 0679.481.238
- VAT number: BE 0679.481.238
- Entity type: Personne morale
- Legal form: Association internationale sans but lucratif
- Status: Active
- Start date: 01 August 2017
Registered office address
The registered office of European Research Infrastructure on Highly Pathogenic Agents is located at: Rue du Trône 98 bte B4, 1050 Ixelles. This address corresponds to the principal place of business declared with the Crossroads Bank for Enterprises and is used for all official correspondence.
Main activity
The main economic activity declared by European Research Infrastructure on Highly Pathogenic Agents is: Recherche-développement en biotechnologie (NACE-BEL code 72101). This activity is listed in the official NACE classification used by Belgian and European authorities to categorise economic sectors.
Peppol e-invoicing
Peppol identifier of European Research Infrastructure on Highly Pathogenic Agents: 0208:0679481238. This identifier allows the sending and receiving of electronic invoices (e-invoicing) over the Peppol network, in compliance with Belgian B2B invoicing regulations.
Active branches
European Research Infrastructure on Highly Pathogenic Agents currently has 1 active branch(es) declared with the KBO/BCE, in addition to its registered office. The full list of branches with details is available further down on this page.
Data updated on 07 April 2026 (source: KBO/BCE).